Dermatologic Infections in the Leukemia and Lymphoma Patient

The presentation discusses dermatologic infections specifically in patients with leukemia and lymphoma, emphasizing their increased susceptibility to infections due to immune suppression caused by myelosuppression, chemotherapy, and the use of immunosuppressive medications. The importance of recognizing altered clinical presentations of infections in these patients, such as a lack of typical signs of inflammation during neutropenia, is highlighted, as this can lead to delayed diagnosis and severe outcomes. Bacterial infections, including both gram-positive and gram-negative organisms, are discussed, along with examples of significant cases like MRSA and Pseudomonas infections. Fungal infections are also common in this population, with Fusarium being noted for its severity and high mortality rate. Viral reactivations, particularly herpes viruses, are prevalent as well, leading to unique challenges such as drug resistance. Additionally, the role of additional pathogens like parasites and mycobacteria is mentioned, underscoring the complexity of managing skin infections in these patients. The presentation concludes with a call for a high degree of clinical suspicion and a multidisciplinary approach to adequately address the various infections encountered in this immunocompromised population.